Best of Psychiatry - January to June 2013

MDLinx® Psychiatry 5 minutes a day to stay current Newsletter Monday, July 15, 2013 1410 new jobs in the Career Center Best of MDLinx - January to June 2013 1. Buprenorphine augmentation in the treatment of refractory obsessive–compulsive disorder Therapeutic Advances in Psychopharmacology 2. Methylphenidate in mania project (MEMAP): study protocol of an international randomised double–blind placebo–controlled study on the initial treatment of acute mania with methylphenidate BMC Psychiatry Full Text    3. Vitamin D deficiency and depression in adults: systematic review and meta–analysis The British Journal of Psychiatry Evidence Based Medicine    4. Curcumin as an Add–On to Antidepressive Treatment: A Randomized, Double–Blind, Placebo–Controlled, Pilot Clinical Study Clinical Neuropharmacology Sponsor 5. Clonazepam for the Treatment of Panic Disorder Current Drug Targets 6. Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double–blind, placebo–controlled pilot study Nutrition Journal Full Text    7. Hypovitaminosis D in Psychiatric Inpatients: Clinical Correlation with Depressive Symptoms, Cognitive Impairment, and Prescribing Practices Psychosomatics 8. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder Australian and New Zealand Journal of Psychiatry 9. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006–2010) International Clinical Psychopharmacology 10. The Combined Treatment of Venlafaxine and Quetiapine for Treatment–Resistant Depression: A Clinical Study The Journal of Neuropsychiatry & Clinical Neurosciences